The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 7, Pages 1527
Publisher
MDPI AG
Online
2019-03-29
DOI
10.3390/ijms20071527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
- (2017) Qiming Duan et al. Science Translational Medicine
- Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond
- (2016) Rohit Moudgil et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
- (2016) Camille Jacques et al. Oncotarget
- BET inhibition as a new strategy for the treatment of gastric cancer
- (2016) Raquel C. Montenegro et al. Oncotarget
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice
- (2015) Y. Sun et al. BLOOD
- The age factor for mitoxantrone’s cardiotoxicity: Multiple doses render the adult mouse heart more susceptible to injury
- (2015) José Luís Dores-Sousa et al. TOXICOLOGY
- BET protein inhibition mitigates acute myocardial infarction damage in rats via the TLR4/TRAF6/NF-κB pathway
- (2015) YANGLI SUN et al. Experimental and Therapeutic Medicine
- Targeting BET bromodomains for cancer treatment
- (2015) Marie Jung et al. Epigenomics
- Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
- (2015) Gong-Quan Li et al. Oncotarget
- Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion
- (2015) Huabo Wang et al. Oncotarget
- Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma
- (2015) Matthew B. Siegel et al. Oncotarget
- JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer
- (2015) Haifeng Qiu et al. Oncotarget
- Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
- (2015) Lei-lei Fu et al. Oncotarget
- BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
- (2015) Grazia Ambrosini et al. Oncotarget
- Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma
- (2015) Tim Hensel et al. Oncotarget
- Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling
- (2015) Anja Heinemann et al. Oncotarget
- Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells
- (2015) Gabor Borbely et al. Oncotarget
- Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.
- (2015) Anastasia Wyce et al. Oncotarget
- BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
- (2015) Anton George Henssen et al. Oncotarget
- Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
- (2015) Marie Loosveld et al. Oncotarget
- Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition
- (2014) Jessica E. Bolden et al. Cell Reports
- BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
- (2013) Priti Anand et al. CELL
- BET acetyl-lysine binding proteins control pathological cardiac hypertrophy
- (2013) Jessica I. Spiltoir et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
- (2012) Jonathan Seal et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mitochondrial Structure, Function and Dynamics Are Temporally Controlled by c-Myc
- (2012) J. Anthony Graves et al. PLoS One
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells
- (2008) Andrey V Kuznetsov et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now